INTRODUCTION
Fas and its ligand FasL are cell-surface proteins whose interaction triggers a cascade of subcellular events that result in apoptosis of the Fas-bearing cell [1, 2] . In lymphoid tissue, FasL is expressed on the cell surface of activated T lymphocytes and natural killer (NK) cells [3] . FasL expression on B lymphocytes is more disputed, as prior studies by Suda et al. [4] claimed that activated B cells do not express FasL. However, several other reports have demonstrated that activated B cells, like activated T cells, can express FasL [5] [6] [7] [8] , which on the cell surface of immune effector cells, is strictly regulated compared with Fas [4, 9] . Once at the cell surface, FasL molecules are cleaved rapidly by a metalloprotease to prevent nonspecific killing by lymphoid cells [10, 11] . The Fas/FasL system plays an essential role in the cytotoxic activity of T and NK cells and in downsizing the pool of activated T lymphocytes that has expanded during an immune response [2, 3] . Engagement of Fas by FasL is also involved in the maintenance of peripheral B cell tolerance and prevention of inopportune T cell help [12, 13] . The functional role of FasL on activated B cells is a matter of controversy. In vivo experiments with normal/FasL-deficient mixed bone marrow chimeras suggested that FasL controls the expansion of lymphocytes only when it is expressed on T cells [14] . In contrast, using a model of Schistosoma mansoni infection, FasL-expressing splenic B cells were shown to mediate CD4 ϩ T cell apoptosis [7] . The occurrence of FasL-mediated B cell-B cell killing remained uncertain until Zuniga et al. [8] investigated the mechanisms involved in B lymphocyte apoptosis during Trypanosoma cruzi infection. They demonstrated that B lymphocyte apoptosis is mediated by Fas/FasL interaction and preferentially affects highly activated B cells specific for parasite antigens.
Dysfunctional Fas signaling, the underlying defect in humans with an autoimmune lymphoproliferative syndrome and the so-called lymphoproliferation (lpr) phenotype in mice, results in a massive accumulation of T cell receptor (TCR)␣␤ ϩ
CD4
-CD8 -[double-negative (DN)] T cells in peripheral lymphoid organs [15, 16] . However, lpr mutation cannot account for the entire autoimmune syndrome of MRL/lpr mice, and other genes of pathologic importance in the MRL background have been mapped [17, 18] .
The DN T cells are derived from CD4 ϩ CD8 -or CD4 -CD8 ϩ [single-positive (SP)] T lymphocytes [19, 20] , which despite antigen stimulations, have not undergone activation-induced cell death because of their defective fas gene [21, 22] . In lpr mice, DN T cells express the B220 molecule. Activated T cells normally up-regulate B220 before undergoing apoptosis. When the apoptotic mechanisms are defective, T cells down-regulate their CD4 or CD8 molecules but retain the B220 expression while residing in lymphoid organs [23] . These DN T cells massively overexpress FasL, which renders them able to kill Fas ϩ targets in vitro [24 -26] . MRL/lpr SP T cells are also endowed with Fas-mediated cytotoxic potential [27] . Furthermore, we have shown that interferon-␣ (IFN-␣) plays an essential role in the overexpression of FasL on MRL/lpr lympho-cytes [28] . The lpr mutation is leaky, and low but detectable levels of transcription [29, 30] and translation [31] of the wild-type Fas molecule have been reported in this strain, as illustrated by the detection of significant amounts of Fas on MRL/lpr hepatocytes, in contrast to hepatocytes from mice rendered completely Fas-deficient by gene targeting [32] . Therefore, the overexpression of FasL by activated MRL/lpr lymphocytes could be responsible for a chronic, nonantigenspecific autoimmune attack on organs expressing low levels of the Fas receptor. The ability of FasL overexpressing T cells to induce a nonantigen-specific autoimmune attack was shown in hematopoietic chimeras created by grafting lethally irradiated wild-type MRL-ϩ/ϩ mice with MRL/lpr lymphoid cells [27, 33] .
In this study, we report that highly purified B lymphocytes from autoimmune MRL/lpr spleen cells express high levels of FasL, comparable with MRL/lpr T lymphocytes and NK cells. Furthermore, they present a cytotoxic activity against Fas ϩ but not Fas targets. These B lymphocytes were used ex vivo without any in vitro activation by B cell stimuli. Within cells of the B lineage, activated B lymphocytes and not plasma cells appear to be responsible for most of the killer activity. To the best of our knowledge, this is the first report of a killer B cell activity in an autoimmune pathology. The contribution of killer B cells to the pathology of the autoimmune MRL/lpr strain is discussed.
MATERIALS AND METHODS

Mice
Wild-type MRL/MpJ (MRL-ϩ/ϩ) and MRL/MpJ-Tnfrsf6 lpr /J mutant mice (MRL/lpr), originally from the Jackson Laboratory (Bar Harbor, ME), were maintained in our animal facilities. All experiments were performed in accordance with the institutional animal research committee guidelines.
Cell preparations
Spleen cell suspensions prepared from several 3-month-old mice were pooled, depleted of erythrocytes by osmotic shock, and deposited onto nylon-wool columns. Effluents, mostly containing T lymphocytes, were enriched further by a second passage through another nylon-wool column. Nylon-wool adherent cells, predominantly containing B lymphocytes and plasma cells, were recovered from the column by adding cold RPMI 1640 and forcibly pushing them out with a plunger. The enriched B cell population was incubated with anti-Thy-1. CD4 ϩ CD8 and CD4 Ϫ CD8 ϩ SP T cells and CD4 Ϫ CD8 DN T cells were purified from T lymphocyte populations enriched using nylon-wool columns. SP T cells were positively selected by MACS technology using L3T4 (antimouse CD4) and Ly-2 (anti-mouse CD8␣) microbeads. Effluents of the columns containing mainly DN T cells were then treated with anti-CD4 and anti-CD8 mAb (respectively, hybridomas GK1-5 and 53-6-72, ATCC) and rabbit complement to avoid any SP T cell contamination.
Cytofluorometric analysis
The expression of different cell-surface antigens on spleen cells, previously incubated with a mAb to mouse Fc receptor for immunogloblulin G (IgG; 2.4G2, PharMingen) to inhibit nonspecific binding, was analyzed by flow cytometry using FITC-, phycoerythrin (PE)-, allophycocyanin (APC)-, or biotin-conjugated mAb or Ig: goat anti-mouse IgM (Sigma Chemical Co., St. Louis, MO) or anti-mouse Ig (PharMingen), rat anti-Thy-1.2 (30-H12, PharMingen), anti-CD3 (CT-CD3, Caltag Laboratories, South San Francisco, CA), anti-CD4 (RM4-5, PharMingen), anti-CD8 (53-6.7, PharMingen), anti-CD49b/ Pan-NK cells (DX5, PharMingen), anti-CD45R/B220 (RA3-6B2, PharMingen), anti-CD19 (1D3, PharMingen), armenian hamster anti-CD69 (H1.2F3, PharMingen), and rat IgM, IgG2a, armenian hamster IgG1, and goat Ig as isotype controls (Serotec France, Cergy Saint-Christophe). The expression of FasL on the cell surface of lymphoid cells was analyzed using a soluble, dimeric Fas:Fc␥1 fusion protein and FITC-conjugated rat mAb anti-mouse IgG1 (A85-1, PharMingen) and mouse IgG1 as a control isotype (PharMingen).
Recombinant mouse Fas:Fc␥1 fusion protein
The soluble, dimeric Fas:Fc␥1 fusion protein consists of the mouse Fas extracellular domain (ligand-binding domain) fused to the Fc portion of mouse IgG1. Fas:Fc␥1 recombinant molecules were produced using a recombinant Adenovirus 5 and purified from the infected HeLa cell-conditioned medium by ammonium sulfate precipitation and affinity chromatography on protein ASepharose.
Semiquantitative reverse transcriptasepolymerase chain reaction (RT-PCR) and real-time RT-PCR
Total RNA was extracted with RNA-Plus (Qbiogene, Illkirch, France) from spleen cells and spleen-cell subpopulations, and 1 g each sample was reverse-transcribed into cDNA using a first-strand cDNA synthesis kit (Amersham Pharmacia Biotech, Orsay, France). Semiquantitative PCR were conducted for 25 cycles with the following primer pairs: FasL forward primer (5Ј-CGT GAG TTC ACC AAC CAA AGC-3Ј) and reverse primer (5Ј-CCC AGT TTC GTT GAT CAC AAG-3Ј); CD 40 ligand (CD40L) forward primer (5Ј-AAA GAT GAG AAG CCA ACT CTG TG-3Ј) and reverse primer (5Ј-ATT GGA TAA GGT CGA AGA GGA AG-3Ј); and hypoxanthine-guanine phosphoribosyl transferase (HGPRT) forward primer (5Ј-GTA ATG ATC AGT CAA CGG GGG AC-3Ј) and reverse primer (5Ј-CCA GCA AGC TTG CAA CCT TAA CCA-3Ј). PCR were performed in a total volume of 25 l in the presence of 2 U Taq polymerase (Promega, Madison, WI); 50 mM KCl; 10 mM Tris-HCl, pH 9; 2.5 mM MgCl 2 ; 0.1% Triton X-100; 0.2 mM each deoxy-unspecified nucleoside 5Ј-triphosphate; 50 pmol forward and reverse primers; and 5 l cDNA at a dilution, which gave similar signals for a cDNA produced with HGPRT primers after electrophoresis on 1% agarose gels in the presence of ethidium bromide and ultraviolet illumination. Amplification conditions were as follows: 1 min at 95°C; 1 min at 50°C for Fas or 60°C for HGPRT, FasL, and CD40L; and 1 min at 72°C for 25 cycles. After PCR, 20 l of the amplified products of each cDNA resolved on 1% agarose gels was blotted and allowed to hybridize with the corresponding radiolabeled oligonucleotide probes: 5Ј-GCT CTG ATC TCT GGA GTG AAG TAT AAG AAA-3Ј for FasL; 5Ј-GGA GTG TTT GAA TTA CAA GCT GG-3Ј for CD40L, and 5Ј-GCT TTC CCT GGT TAA GCA GTA CAG CCC C-3Ј for HGPRT to verify that the bands were specific. Semiquantitative determination (PhosphoImager System, Molecular Dynamics, Sunnyvale, CA) of FasL cDNA, present in each of the various samples, was normalized with respect to the concentration of HGPRT cDNA detected in the same sample, and FasL/HGPRT cDNA ratios were calculated.
Real-time quantitative PCR was conducted with the LightCycler system using the DNA binding dye SYBR Green for the detection of PCR products according to the manufacturer's instructions (Roche Diagnostics, Mannheim, Germany). In brief, total RNA was isolated and reverse-transcribed as for conventional RT-PCR. Quantitative PCR was performed in a total volume of 20 l in the presence of 2 l cDNA, 2 l 10ϫ LightCycler DNA Master SYBR Green I, 1.25 mM MgCl 2, 25 pmol each primer. Primers for FasL and HGPRT have been described above. After being heated at 95°C for 8 min, cDNA was amplified for 35 cycles, each cycle consisting of 95°C for 15 s, 60°C for 5 s, and 72°C for 8 s. For melting curve analysis, samples were heated to 95°C at a transition rate of 0.1°C/s with continuous fluorescence readings. The specificity of PCR products was confirmed by melting curve analysis and by running samples on agarose gels. Specific cDNA was quantified by standard curves based on known amounts of product. Standards were generated from amplified cDNA purified on agarose gels by QiaQuick gel extraction (Qiagen, Courtaboeuf, France) and quantified by spectrophotometry (optical density of 260). The standards and the samples were simultaneously amplified using the same reaction master mixture.
Cytotoxicity assay
Murine target cells consisted of sodium [
51 Cr]chromate-labeled thymocytes distributed in U-shaped wells (5ϫ10 4 per well) of microtiter plates with spleen cells or subpopulations purified from spleen cells as effector cells at the effector-to-target (E:T) ratios indicated in 200 l medium containing 5% fetal calf serum supplemented or not with a mixture of phorbol 12-myristate 13-acetate (PMA; final concentration, 5 ng/ml; P-8139, Sigma Chemical Co.) plus ionomycin (final concentration, 0.5 g/ml; 407952, Calbiochem, San Diego, CA). After a 4-h incubation, microplates were processed as described previously [26] , and the SEM (ϮSE) for specific 51 Cr release of triplicates were always Ͻ5%. In some experiments, cytotoxicity was assessed in the presence of soluble, dimeric Fas:Fc␥1 fusion protein (1 M).
Statistical analysis
Data are reported as the mean Ϯ SE. Comparisons were made by Student's t-test. Statistical difference was accepted at P Ͻ 0.05.
RESULTS
T and B cell lymphoproliferation in MRL/lpr mice
Flow cytometric analyses indicated that in MRL/lpr mice, splenic B cell lymphoproliferation starts at 2 months. At 5 months, analyses obtained for 20 animals show that the IgM ϩ B220 ϩ B cell population is four-to fivefold larger than in wild-type MRL-ϩ/ϩ mice (mean B cell numbersϫ10 7 ϮSE: 9.02Ϯ0.92 vs. 1.9Ϯ0.3, respectively; PϽ0.001). This is in parallel to the massive (200-fold increase), well-documented CD4
Ϫ CD8 DN T cell prolifer-
Fas-mediated killing by MRL/lpr T and B cells
According to our previously published data [26] , total spleen cells and nylon-wool nonadherent T lymphocytes from MRL/lpr mice trigger the death of Fas ϩ thymocytes upon stimulation with a mixture of PMA plus ionomycin, which mimics TCR activation (Fig. 1) -non-T, non-B cells) from MRL-ϩ/ϩ mice (nϭ8) were activated by PMA plus ionomycin and subsequently used as effector cells (Fig. 1) .
FasL expression by T and B cells
FasL expression was determined, in parallel to the expressions of CD40L and HGPRT, using semiquantitative RT-PCR analysis on mRNA isolated from the different spleen cell subpopu- lations of MRL/lpr and wild-type MRL-ϩ/ϩ mice. As we previously reported [26] , the nylon-wool nonadherent T cell population overexpressed FasL when purified from MRL/lpr spleen cells (Fig. 2A) . In addition, CD40L is up-regulated in MRL/lpr SP T lymphocytes reflecting their state of activation in vivo. Expression of CD40L was restricted to MRL/lpr SP as opposed to DN T cells (thereby explaining the weak band in whole T cells), and a faint signal was observed in MRL-ϩ/ϩ SP T lymphocytes (Fig. 2A) .
The surface expression of FasL on MRL/lpr and MRL-ϩ/ϩ spleen cell subpopulations was determined by flow cytometry using soluble, recombinant Fas:Fc␥1 fusion protein, anti-CD3, and anti-CD19 mAb. As expected, the FasL molecule is overexpressed on the MRL/lpr T cell population, especially on DN T cells (Fig. 3A and data not shown) . In line with the FasL mRNA quantification, the FasL molecule is overexpressed also on the surface of MRL/lpr CD19 ϩ B cells. Moreover, MRL/lpr CD19 ϩ B cells with the highest FSC value showed the highest expression of FasL (Fig. 3B) ) T cells were never detected (data not shown). In addition, we examined the surface expression of the early activation marker CD69, which has been shown to be up-regulated after B cell receptor stimulation in primary lymphocytes. The percentage of CD69 ϩ cells in the B cell population of MRL/lpr mice was significantly higher than that of wild-type MRL-ϩ/ϩ mice (meansϮSE from 12 mice: 27Ϯ0.95% vs. 6.8Ϯ2%, respec- 
tively; PϽ0.001).
ϩ CD19 ϩ B cells (Fig.  3C) . Hence, FasL expression is associated with B cell activation status.
Fas-mediated killing by MRL/lpr T, NK, and B cells
The nylon-wool adherent MRL/lpr spleen cells depleted of Thy-1.2 lymphocytes by antibody plus complement (mostly B lymphocytes) contained, as shown by flow cytometry analysis (Fig. 4A) : 26% large granular cells in the FSC high sidescatter high (SSC) gate; 16 -22% of these cells expressed the NK epitope, DX5, and the B220 B cell marker, also found on some NK1.1 ϩ cells [34] . The DX5 ϩ NK cell population represents 0.1-1% of unfractionated spleen cells in MRL/lpr and MRL-ϩ/ϩ strains. Therefore, a difference in the number of NK cells contaminating nylon-wool adherent spleen cells cannot account for the different cytotoxic abilities of these subpopulations (Fig. 1) . Nevertheless, to determine whether these NK cells could be responsible for the killing capacity of nylon-wool adherent cells, DX5-and Thy-1.2-positive cells were depleted immunomagnetically. Purified B cells, contaminated with Ͻ2% cells labeled with Thy1.2 and DX5 antibodies, as shown by cytofluorometric analysis, still retained a substantial Fasdependent cytotoxic activity (Fig. 4B, upper) . The cytotoxicity of B lymphocytes was dependent strictly on Fas/FasL interaction, as the soluble Fas:Fc␥1 fusion protein inhibited specifically, in a dose-dependent manner, the B cell cytotoxicity on Fas ϩ thymocytes, and the control fusion protein (secreted alkaline phosphatase Fc) had no effect (data not shown). As expected, the positively selected Thy-1.2 ϩ or DX5 ϩ populations (T and NK cells, respectively) were potent effectors of Fas-mediated cytotoxicity (Fig. 4B, upper) .
As plasma cells (Syndecan-1 ϩ ) were present along with B cells in the nylon-wool adherent population, Syndecan-1 ϩ (90% of which were B220 -) and Syndecan-1 -(81% B220 ϩ ) cells were separated immunomagnetically. Syndecan-1 is a member of the Syndecan family of integral membrane proteoglycans expressed by pre-B cells and plasma cells but absent from circulating, mature B cells [35] . Figure 4B (lower) shows that the B cell (Syndecan-1 -) population was responsible for most of the cytotoxic activity, and plasma cells exerted a much lower capacity.
DISCUSSION
Following the studies by Suda et al. [4] , it was considered that only T-tropic mitogens (concanavalin A or anti-CD3) induced FasL mRNA expression, whereas B-tropic mitogens [lipopolysaccharide (LPS) or anti-IgM] did not. In addition, among cytokines, only a high concentration of interleukin-2 substantially induced FasL mRNA expression. However, Hahne et al. [5] subsequently found that a T cell-depleted spleen cell population expressed FasL and became Fas-dependent cytotoxic effectors when subjected to extensive stimulation by LPS (3-4 days) followed by 14 h of incubation with medium containing a mixture of PMA plus ionomycin, which mimics B cell receptor activation. Thereafter, additional reports (including the present report) demonstrated that activated B cells, like activated T cells, can express functional FasL [6 -8, 36] . The present work shows, using a semiquantitative RT-PCR assay, that T-depleted spleen cells from MRL/lpr mice expressed FasL when tested ex vivo in the absence of any further stimulation. The level of FasL mRNA is comparable with or higher than the one measured in MRL/lpr splenic SP or DN T lymphocytes. The accuracy of the method's semiquantitative evaluations was demonstrated by the specific detection of CD40L on MRL/lpr SP T lymphocytes but not on DN T cells, a finding in agreement with the transient expression of this costimulatory molecule following T cell antigen receptor activation [37] . Indeed, DN T cells are persistent, previously activated SP cells, which have failed to undergo apoptosis [19, 20] . It is unexpected that we found by quantitative real-time RT-PCR that B lymphocytes from MRL/lpr mice, but not from MRL-ϩ/ϩ, express more FasL RNA than SP T lymphocytes. Moreover, in some MRL/lpr mice, the level of FasL in B cells reached the one found in DN T cells. Then, we checked whether the overexpression of FasL mRNA in B lymphocytes was also found at the protein level. Our analyses were focused on the membrane-anchored FasL. To this end, the expression of FasL was analyzed by flow cytometry using a soluble, recombinant Fas:Fc␥1 fusion protein, anti-CD3, and anti-CD19 mAb. We observed that B and T lymphocyte populations from MRL/lpr mice overexpressed membrane FasL. Furthermore, we found that the level of membrane-anchored FasL increased with the size of the B cell and up-regulation of the early activation marker CD69, suggesting that the expression of FasL might be controlled by the activation state of the B cell. Our data are reminiscent of recent findings, which showed that FasL is expressed on large, highly activated B cells during a T. cruzi infection [8] .
Using primers that amplify Fas receptor cDNA products beyond the transposon insertion and therefore detect the predominant mutated and the minor wild-type transcripts, we have observed a Fas overexpression in all MRL/lpr spleen subpopulations (data not shown). This observation could explain the differences observed between MRL/lpr and Fas knockout strains [32] . Indeed, in MRL/lpr mice, the lpr-mutated and minor (ϳ2%) wild-type Fas transcripts [29] might be augmented with age to reach significant levels. This could have pathological consequences, because of the FasL overexpression by MRL/lpr lymphocyte subpopulations.
The T cell-depleted spleen population, mostly comprising B cells, was able to kill Fas-expressing thymocytes specifically. Flow cytometry analyses revealed that this population contained 4 -6% large granular (DX5 ϩ ) NK cells. When isolated immunomagnetically, these DX5 ϩ NK cells were potent, in vitro, cytotoxic effectors. It is surprising that under the same conditions, the remaining B220 
DX5
-cells still exerted cytotoxicity against Fas ϩ targets. Isolation of the cells lacking or expressing Syndecan-1, an integral membrane proteoglycan expressed by pre-B cells and plasma cells but absent from mature peripheral B cells [35] , indicated that this cytotoxicity was predominantly a result of mature B lymphocytes expressing the B220 ϩ Syndecan-1 -phenotype. FasL expression on B cells may have important immunopathological implications. Systemic lupus erythematosus (SLE), a prototype of systemic autoimmune disease, is generally thought to be solely antibody-mediated and characterized by deposits of autoantibodies and immune complexes in kidneys, vessels, skin, and salivary glands [38] . However, lymphoid cell infiltration of organs, such as lung, kidney, and skin, are also prominent features in SLE patients as well as their murine models, and the relative role of humoral and cellular immunities has not been defined clearly yet. In addition to autoantibody production, the autoimmune disease of MRL/lpr mice is characterized by skin lesions [39] , glomerulonephritis [40] , and vasculitis [41] . B cells are necessary for the development of nephritis and vasculitis [42, 43] . Indeed, the T cell-restricted expression of transgenic Fas in MRL/lpr mice blocks the lymphoproliferation but not the glomerulonephritis [44] . Furthermore, it has been shown that mice with B cells but lacking serum antibodies still develop these pathologies, underlining an antibody-independent mechanism for renal and vascular disease in SLE. The mechanism suggested by Chan et al. [45] implicated the APC function of B cells. In the MRL/lpr SLE model, an alternative explanation could be that expanding B cells, which overexpress FasL but cannot be eliminated properly, may contribute, together with T cells, to the cytotoxic destruction of Fas-bearing tissues. This expression of Fas could be constitutive or result from induction by proinflammatory cytokines, such as IFN-␥, which is also required for the development of MRL/lpr glomerulonephritis [46, 47] .
In conclusion, our data demonstrate the cytotoxic activity of MRL/lpr activated B cells on Fas ϩ targets. This finding suggests a new role for activated B lymphocytes in the autoimmune destruction of Fas-bearing inflammatory tissues, which could lead to new therapeutic approaches to B cell-dependent nephritis and vasculitis in SLE patients.
